false 0001937653 0001937653 2024-08-30 2024-08-30

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 30, 2024

 

 

Zymeworks Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-41535   88-3099146
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

108 Patriot Drive, Suite A

Middletown, Delaware

(Address of principal executive offices)

 

19709

(Zip Code)

(302) 274-8744

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, par value $0.00001 per share   ZYME   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As previously reported on the Current Report on Form 8-K filed on July 25, 2024 (the “Prior 8-K”) by Zymeworks Inc. (the “Company”), the Company’s board of directors (the “Board”) appointed Ms. Leone Patterson, age 61, as Executive Vice President, Chief Business Officer and Chief Financial Officer of the Company, effective upon her commencement of employment with the Company, which was anticipated to be September 1, 2024. Ms. Patterson’s employment with the Company commenced on September 1, 2024 (the “Start Date”). On August 30, 2024, Mr. Kenneth Galbraith resigned from the positions of interim Chief Financial Officer and as principal financial officer and principal accounting officer of the Company, effective as of the Start Date. Mr. Galbraith will continue in his roles as Chair of the Board, Chief Executive Officer and President of the Company and the compensatory and other material terms of Mr. Galbraith’s employment with the Company will remain unchanged. For additional information regarding Ms. Patterson’s appointment and the compensatory arrangements related thereto, please refer to the Prior 8-K.

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

       

ZYMEWORKS INC.

    (Registrant)
Date: September 3, 2024     By:  

/s/ Kenneth Galbraith

   

Name:

Title:

 

Kenneth Galbraith

Chair, Chief Executive Officer and President

 

3

v3.24.2.u1
Document and Entity Information
Aug. 30, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001937653
Document Type 8-K
Document Period End Date Aug. 30, 2024
Entity Registrant Name Zymeworks Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-41535
Entity Tax Identification Number 88-3099146
Entity Address, Address Line One 108 Patriot Drive
Entity Address, Address Line Two Suite A
Entity Address, City or Town Middletown
Entity Address, State or Province DE
Entity Address, Postal Zip Code 19709
City Area Code (302)
Local Phone Number 274-8744
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.00001 per share
Trading Symbol ZYME
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

Zymeworks (NASDAQ:ZYME)
過去 株価チャート
から 9 2024 まで 10 2024 Zymeworksのチャートをもっと見るにはこちらをクリック
Zymeworks (NASDAQ:ZYME)
過去 株価チャート
から 10 2023 まで 10 2024 Zymeworksのチャートをもっと見るにはこちらをクリック